APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tacrolimus Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tacrolimus Injection Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchTacrolimus Injection Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Tacrolimus Injection Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Tacrolimus Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tacrolimus Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Tacrolimus Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Tacrolimus Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tacrolimus Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tacrolimus Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tacrolimus Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tacrolimus Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tacrolimus Injection market include Pfizer, Astellas Pharma and Jina Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tacrolimus Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tacrolimus Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tacrolimus Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tacrolimus Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Tacrolimus Injection Segment by Company

Pfizer

Astellas Pharma

Jina Pharma

Tacrolimus Injection Segment by Type

5 mg/mL

Others

Tacrolimus Injection Segment by Application

Adult

Children

Tacrolimus Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Tacrolimus Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tacrolimus Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tacrolimus Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Tacrolimus Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tacrolimus Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tacrolimus Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tacrolimus Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tacrolimus Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tacrolimus Injection industry.

Chapter 3: Detailed analysis of Tacrolimus Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tacrolimus Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tacrolimus Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tacrolimus Injection Industry Trends Table 2. Tacrolimus Injection Industry Drivers Table 3. Tacrolimus Injection Industry Opportunities and Challenges Table 4. Tacrolimus Injection Industry Restraints Table 5. Global Tacrolimus Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tacrolimus Injection Revenue Share by Company (2021-2026) Table 7. Global Tacrolimus Injection Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Tacrolimus Injection Sales Volume Share by Company (2021-2026) Table 9. Global Tacrolimus Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Tacrolimus Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tacrolimus Injection Key Company Manufacturing Base & Headquarters Table 12. Global Tacrolimus Injection Company, Product Type & Application Table 13. Global Tacrolimus Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tacrolimus Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5 mg/mL Table 18. Significant Companies of Others Table 19. Global Tacrolimus Injection Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Tacrolimus Injection Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Tacrolimus Injection Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Tacrolimus Injection Sales Volume Share by Type (2021-2026) Table 23. Global Tacrolimus Injection Sales Volume Share by Type (2027-2032) Table 24. Global Tacrolimus Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tacrolimus Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Tacrolimus Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Tacrolimus Injection Sales Value Share by Type (2021-2026) Table 28. Global Tacrolimus Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adult Table 30. Significant Companies of Children Table 31. Global Tacrolimus Injection Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Tacrolimus Injection Sales Volume by Application (2021-2026) & (W Units) Table 33. Global Tacrolimus Injection Sales Volume by Application (2027-2032) & (W Units) Table 34. Global Tacrolimus Injection Sales Volume Share by Application (2021-2026) Table 35. Global Tacrolimus Injection Sales Volume Share by Application (2027-2032) Table 36. Global Tacrolimus Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Tacrolimus Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Tacrolimus Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Tacrolimus Injection Sales Value Share by Application (2021-2026) Table 40. Global Tacrolimus Injection Sales Value Share by Application (2027-2032) Table 41. Global Tacrolimus Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Tacrolimus Injection Sales by Region (2021-2026) & (W Units) Table 43. Global Tacrolimus Injection Sales Market Share by Region (2021-2026) Table 44. Global Tacrolimus Injection Sales by Region (2027-2032) & (W Units) Table 45. Global Tacrolimus Injection Sales Market Share by Region (2027-2032) Table 46. Global Tacrolimus Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Tacrolimus Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Tacrolimus Injection Sales Value Share by Region (2021-2026) Table 49. Global Tacrolimus Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Tacrolimus Injection Sales Value Share by Region (2027-2032) Table 51. Global Tacrolimus Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Tacrolimus Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Tacrolimus Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Global Tacrolimus Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Tacrolimus Injection Sales by Country (2021-2026) & (W Units) Table 56. Global Tacrolimus Injection Sales Market Share by Country (2021-2026) Table 57. Global Tacrolimus Injection Sales by Country (2027-2032) & (W Units) Table 58. Global Tacrolimus Injection Sales Market Share by Country (2027-2032) Table 59. Global Tacrolimus Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Tacrolimus Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Tacrolimus Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Tacrolimus Injection Sales Value Market Share by Country (2027-2032) Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Tacrolimus Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pfizer Tacrolimus Injection Product Portfolio Table 67. Pfizer Recent Development Table 68. Astellas Pharma Company Information Table 69. Astellas Pharma Business Overview Table 70. Astellas Pharma Tacrolimus Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Astellas Pharma Tacrolimus Injection Product Portfolio Table 72. Astellas Pharma Recent Development Table 73. Jina Pharma Company Information Table 74. Jina Pharma Business Overview Table 75. Jina Pharma Tacrolimus Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Jina Pharma Tacrolimus Injection Product Portfolio Table 77. Jina Pharma Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Tacrolimus Injection Distributors List Table 81. Tacrolimus Injection Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Tacrolimus Injection Product Image Figure 2. Global Tacrolimus Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tacrolimus Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tacrolimus Injection Sales (2021-2032) & (W Units) Figure 5. Global Tacrolimus Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Tacrolimus Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5 mg/mL Image Figure 10. Others Image Figure 11. Global Tacrolimus Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Tacrolimus Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Tacrolimus Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Tacrolimus Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Tacrolimus Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Tacrolimus Injection Sales Value Share by Type (2021-2032) Figure 17. Adult Image Figure 18. Children Image Figure 19. Global Tacrolimus Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Tacrolimus Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Tacrolimus Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Tacrolimus Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Tacrolimus Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Tacrolimus Injection Sales Value Share by Application (2021-2032) Figure 25. Global Tacrolimus Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 26. Global Tacrolimus Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Tacrolimus Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Tacrolimus Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Tacrolimus Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Tacrolimus Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Tacrolimus Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Tacrolimus Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Tacrolimus Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Tacrolimus Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Tacrolimus Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Tacrolimus Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Tacrolimus Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Tacrolimus Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Tacrolimus Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Tacrolimus Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Tacrolimus Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg/mL
  • Others
Applications
  • Adult
  • Children
Companies covered
  • Pfizer
  • Astellas Pharma
  • Jina Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tacrolimus Injection Sales Value (2021-2032)
  4. 1.2.2 Global Tacrolimus Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Tacrolimus Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tacrolimus Injection Market Dynamics
  1. 2.1 Tacrolimus Injection Industry Trends
  2. 2.2 Tacrolimus Injection Industry Drivers
  3. 2.3 Tacrolimus Injection Industry Opportunities and Challenges
  4. 2.4 Tacrolimus Injection Industry Restraints
3 Tacrolimus Injection Market by Company
  1. 3.1 Global Tacrolimus Injection Company Revenue Ranking in 2025
  2. 3.2 Global Tacrolimus Injection Revenue by Company (2021-2026)
  3. 3.3 Global Tacrolimus Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Tacrolimus Injection Average Price by Company (2021-2026)
  5. 3.5 Global Tacrolimus Injection Company Ranking (2024-2026)
  6. 3.6 Global Tacrolimus Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Tacrolimus Injection Company Product Type and Application
  8. 3.8 Global Tacrolimus Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tacrolimus Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tacrolimus Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tacrolimus Injection Market by Type
  1. 4.1 Tacrolimus Injection Type Introduction
  2. 4.1.1 5 mg/mL
  3. 4.1.2 Others
  4. 4.2 Global Tacrolimus Injection Sales Volume by Type
  5. 4.2.1 Global Tacrolimus Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tacrolimus Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Tacrolimus Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Tacrolimus Injection Sales Value by Type
  9. 4.3.1 Global Tacrolimus Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tacrolimus Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Tacrolimus Injection Sales Value Share by Type (2021-2032)
5 Tacrolimus Injection Market by Application
  1. 5.1 Tacrolimus Injection Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Tacrolimus Injection Sales Volume by Application
  5. 5.2.1 Global Tacrolimus Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Tacrolimus Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Tacrolimus Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Tacrolimus Injection Sales Value by Application
  9. 5.3.1 Global Tacrolimus Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Tacrolimus Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Tacrolimus Injection Sales Value Share by Application (2021-2032)
6 Tacrolimus Injection Regional Sales and Value Analysis
  1. 6.1 Global Tacrolimus Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tacrolimus Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Tacrolimus Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Tacrolimus Injection Sales by Region (2027-2032)
  5. 6.3 Global Tacrolimus Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tacrolimus Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tacrolimus Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tacrolimus Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Tacrolimus Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tacrolimus Injection Sales Value (2021-2032)
  12. 6.6.2 North America Tacrolimus Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tacrolimus Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Tacrolimus Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tacrolimus Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tacrolimus Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tacrolimus Injection Sales Value (2021-2032)
  21. 6.9.2 South America Tacrolimus Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tacrolimus Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tacrolimus Injection Sales Value Share by Country, 2025 VS 2032
7 Tacrolimus Injection Country-level Sales and Value Analysis
  1. 7.1 Global Tacrolimus Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tacrolimus Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tacrolimus Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Tacrolimus Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Tacrolimus Injection Sales by Country (2027-2032)
  6. 7.4 Global Tacrolimus Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tacrolimus Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tacrolimus Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tacrolimus Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tacrolimus Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tacrolimus Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Tacrolimus Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Tacrolimus Injection Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Astellas Pharma
  8. 8.2.1 Astellas Pharma Company Information
  9. 8.2.2 Astellas Pharma Business Overview
  10. 8.2.3 Astellas Pharma Tacrolimus Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Astellas Pharma Tacrolimus Injection Product Portfolio
  12. 8.2.5 Astellas Pharma Recent Developments
  13. 8.3 Jina Pharma
  14. 8.3.1 Jina Pharma Company Information
  15. 8.3.2 Jina Pharma Business Overview
  16. 8.3.3 Jina Pharma Tacrolimus Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jina Pharma Tacrolimus Injection Product Portfolio
  18. 8.3.5 Jina Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tacrolimus Injection Value Chain Analysis
  2. 9.1.1 Tacrolimus Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tacrolimus Injection Sales Mode & Process
  6. 9.2 Tacrolimus Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tacrolimus Injection Distributors
  9. 9.2.3 Tacrolimus Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst